Oncology Institute (TOIIW) Change in Accured Expenses (2020 - 2026)

Oncology Institute (TOIIW) has reported Change in Accured Expenses for 7 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $3.9 million, up 52.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $903000.0 (down 86.46% YoY), and the FY2025 annual result was -$448000.0, down 104.73% from the prior year.
• Change in Accured Expenses was $3.9 million for Q1 2026 at Oncology Institute, up from -$2.8 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $5.4 million in Q1 2024 and troughed at -$3.4 million in Q2 2024.
• Average Change in Accured Expenses over 5 years is $1.1 million, with a median of $526000.0 recorded in 2022.
• Year-over-year, Change in Accured Expenses slumped 332.23% in 2023 and jumped 766.83% in 2024.
• Over 5 years, Change in Accured Expenses stood at -$545000.0 in 2022, then soared by 609.72% to $2.8 million in 2023, then soared by 67.6% to $4.7 million in 2024, then plunged by 160.93% to -$2.8 million in 2025, then soared by 238.1% to $3.9 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $3.9 million in Q1 2026, -$2.8 million in Q4 2025, and $127000.0 in Q3 2025.